Migdal Insurance & Financial Holdings’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,340
Closed -$133K 816
2019
Q3
$133K Sell
1,340
-30
-2% -$2.85K ﹤0.01% 521
2019
Q2
$127K Buy
1,370
+1,340
+4,467% +$127K ﹤0.01% 539
2019
Q1
$3K Hold
30
﹤0.01% 690
2018
Q4
$2K Sell
30
-5,017
-99% -$370K ﹤0.01% 691
2018
Q3
$452K Buy
5,047
+2,958
+142% +$261K 0.01% 392
2018
Q2
$166K Buy
2,089
+1,990
+2,010% +$165K ﹤0.01% 455
2018
Q1
$9K Sell
99
-621
-86% -$59.6K ﹤0.01% 560
2017
Q4
$75K Sell
720
-1,100
-60% -$124K ﹤0.01% 392
2017
Q3
$265K Sell
1,820
-4,970
-73% -$677K 0.01% 284
2017
Q2
$895K Buy
6,790
+1,950
+40% +$239K 0.02% 171
2017
Q1
$602K Buy
4,840
+3,840
+384% +$460K 0.01% 187
2016
Q4
$117K Buy
+1,000
New +$111K ﹤0.01% 299

Other funds holding CELG

Migdal Insurance & Financial Holdings's CELG Position: Q4 2019 in Review

Migdal Insurance & Financial Holdings sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,340 shares — an estimated $133K sold.

Migdal Insurance & Financial Holdings first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $895K in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Migdal Insurance & Financial Holdings reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 1,340 Celgene Corp shares in Q4 2019, an estimated $133K.
  • Migdal Insurance & Financial Holdings first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Migdal Insurance & Financial Holdings's Celgene Corp position peaked at $895K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2019, filed 13 Feb 2020.